top of page

FOCUS

a mobile health intervention

for people with serious mental illness

FOCUS...

is usable, acceptable,
and clinically promising

Symptom measures suggest clinical gains

Participants reported FOCUS easy to use and acceptable

FOCUS was tested in a 30-day single arm trial. N=33 participated.

​

Participants used FOCUS 86.5% of days they had it, avg. 5x a day.

is engaging to high risk patients

Participants engaged with FOCUS 82% of weeks 

FOCUS was deployed as part of a multi-modal relapse prevention program across 8 states. 

​

Participants were at high-risk for relapse. All had a psychotic disorder.

​

N=342 participated for 6 months.

has similar outcomes to clinic-based care

FOCUS was compared in a randomized controlled effectiveness trial with a clinic-based program.

​

N=163 participated for 3 months.

Engagement was higher and clinical and recovery outcomes were similar.

bottom of page